Biotech News
Exagen Inc. Reports Strong Q3 2025 Results
investors.exagen.com2026-05-06 15:13 EST
CARLSBAD, Calif. , Nov. 04, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended September 30, 2025 , and recent corporate updates. Three Months Ended September 30 , Nine Months Ended